STAT October 18, 2024
Ed Silverman

The 340B Drug Discount Program was intended to serve hospitals and clinics serving lower-income patients

Prescription medicines purchased in the U.S. under a controversial government discount program amounted to $63 billion in 2023, a 23.4% increase from the previous year, according to the Health Resources & Services Administration, which oversees the program.

The data mark a steady rise...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Precision Medicine Hinges On Access To Genetic Counselors
RNA editing: emerging from CRISPR’s shadow
Editas Medicine Seeks Partner for Ex Vivo Gene-Editing Program as Focus Turns to In Vivo R&D
Dotmatics aims to speed drug development, break data silos with Geneious Luma
1st sickle cell gene therapy patient completes treatment

Share This Article